FINWIRES · TerminalLIVE
FINWIRES

Capital One Upgrades NOV to Overweight From Equal Weight, Adjusts Price Target to $26 From $25

By

NOV (NOV) has an average rating of Hold and mean price target of $21.94, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Gordon Haskett Upgrades Dollar Tree to Hold From Reduce, Raises Price Target to $115 From $100

Dollar Tree (DLTR) has an average rating of hold and mean price target of $125.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$DLTR
Research

Descartes Systems Price Targets Adjusted at CIBC, Raymond James

Analysts at CIBC Capital Markets and Raymond James adjusted their price targets on Descartes Systems Group Inc. (DSG.TO, DSGX).CIBC Analyst Stephanie Price raised her price target on the Canadian multinational software company to US$118 from US$116, and maintained an Outperformer rating following its Q1 results."The freight environment remains volatile, with Descartes noting lower shipment volumes in the quarter," Price said in a note to clients."Descartes continues to roll out AI agents to help clients monitor and respond to logistics disruptions and is leveraging AI internally to improve efficiency," the analyst said."The company remains well capitalized, with $377 Million in net cash to spend on M&A and/or its NCIB," Price said.Raymond James analyst Steven Li lowered his price target to US$108 from US$118, and maintained an Outperform rating."Fundamental set-up looks strong with improving organic growth into easier comps," Li said in a note to clients."M&A set-up sounded good, too, and we believe combined with the improving organic growth, could push A-EBITDA into a period of heightened growth (high-teens, this 1Q already A-EBITDA was +20% y/y)," the analyst said."This level of EBITDA growth has compounding implications as over the last 10 years; DSGX has converted on average 84% of its A-EBITDA into FCF like clockwork."

$DSG.TO$DSGX
Research

Wedbush Adjusts Price Target on Innodata to $120 From $100, Maintains Outperform Rating

$INOD